927 related articles for article (PubMed ID: 30338636)
1. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
Sargin G; Senturk T; Yavasoglu I; Kose R
Int J Rheum Dis; 2018 Dec; 21(12):2122-2127. PubMed ID: 30338636
[TBL] [Abstract][Full Text] [Related]
2. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
Uslu AU; Küçük A; Şahin A; Ugan Y; Yılmaz R; Güngör T; Bağcacı S; Küçükşen S
Int J Rheum Dis; 2015 Sep; 18(7):731-5. PubMed ID: 25900081
[TBL] [Abstract][Full Text] [Related]
3. The value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study.
Jin Z; Cai G; Zhang P; Li X; Yao S; Zhuang L; Ren M; Wang Q; Yu X
J Clin Lab Anal; 2021 Jan; 35(1):e23569. PubMed ID: 32951253
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis.
Fu H; Qin B; Hu Z; Ma N; Yang M; Wei T; Tang Q; Huang Y; Huang F; Liang Y; Yang Z; Zhong R
Clin Lab; 2015; 61(3-4):269-73. PubMed ID: 25974992
[TBL] [Abstract][Full Text] [Related]
5. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
[TBL] [Abstract][Full Text] [Related]
6. Role of Platelet/Lymphocyte, Neutrophil/Lymphocyte, and Interleukin-37/Interleukin-17 Ratios in the Occurrence and Treatment of Rheumatoid Arthritis.
Meng Y; Cai XL; Cong S; Sun J; Hu YW; Gu YQ; Ma XM; Luo L
Immunol Invest; 2024 Apr; 53(3):464-474. PubMed ID: 38477623
[TBL] [Abstract][Full Text] [Related]
7. [Neutrophil-lymphocyte and platelet-lymphocyte ratios for assessing disease activity in patients with rheumatoid arthritis receiving tofacitinib treatment].
Tang J; Chen J; Lin G; Zhang H; Gui M; Li N; Gu Y; Luo L; Sun J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1651-1656. PubMed ID: 37933639
[TBL] [Abstract][Full Text] [Related]
8. Overlooked hematological markers of disease activity in rheumatoid arthritis.
Tekeoğlu İ; Gürol G; Harman H; Karakeçe E; Çiftçi İH
Int J Rheum Dis; 2016 Nov; 19(11):1078-1082. PubMed ID: 26620362
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
Asahina A; Kubo N; Umezawa Y; Honda H; Yanaba K; Nakagawa H
J Dermatol; 2017 Oct; 44(10):1112-1121. PubMed ID: 28493493
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritis: a retrospective chart review analysis.
Lee HN; Kim YK; Kim GT; Ahn E; So MW; Sohn DH; Lee SG
Rheumatol Int; 2019 May; 39(5):859-868. PubMed ID: 30874873
[TBL] [Abstract][Full Text] [Related]
11. The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy.
Boulos D; Proudman SM; Metcalf RG; McWilliams L; Hall C; Wicks IP
Semin Arthritis Rheum; 2019 Dec; 49(3):373-376. PubMed ID: 31248587
[TBL] [Abstract][Full Text] [Related]
12. Relationship of hematologic markers with IL-17 and IL-1 beta in patients with rheumatoid arthritis.
Sağ S; Sağ MS; Tekeoğlu I; Kamanlı A; Nas K; Acar BA
J Back Musculoskelet Rehabil; 2018; 31(4):703-707. PubMed ID: 29578474
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios may not be useful markers to assess disease activity in rheumatoid arthritis: A STROBE-compliant article.
Lijuan W; Yuting Z; Chaoyang L; Ju Y
Medicine (Baltimore); 2021 Nov; 100(45):e27631. PubMed ID: 34766563
[TBL] [Abstract][Full Text] [Related]
14. Association between Hematological Indicesand Disease Activity in Patients with Rheumatoid Arthritis Treated with Janus Kinase Inhibitors for 24 Weeks.
Choe JY; Kim SK
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334603
[TBL] [Abstract][Full Text] [Related]
15. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
Pan L; Du J; Li T; Liao H
BMJ Open; 2017 May; 7(4):e014451. PubMed ID: 28473512
[TBL] [Abstract][Full Text] [Related]
16. The Relationship between Hematological Markers of Systemic Inflammation (Neutrophil-To-Lymphocyte, Platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and Ultrasound Disease Activity Parameters in Patients with Rheumatoid Arthritis.
Targońska-Stępniak B; Zwolak R; Piotrowski M; Grzechnik K; Majdan M
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858869
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis.
Chandrashekara S; Rajendran A; Bai Jaganath A; Krishnamurthy R
Reumatismo; 2015 Dec; 67(3):109-15. PubMed ID: 26876190
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab.
Zhou L; Xiao DM; Qin W; Xie BH; Wang TH; Huang H; Zhao BJ; Han X; Sun QQ; Wu XD; Cen H
J Clin Lab Anal; 2019 Jun; 33(5):e22862. PubMed ID: 30779461
[TBL] [Abstract][Full Text] [Related]
19. Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.
Bozan N; Alpaycı M; Aslan M; Cankaya H; Kıroglu AF; Turan M; Ayral A; Senkoy E; Ilter S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3663-3672. PubMed ID: 27034281
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients.
Qin B; Ma N; Tang Q; Wei T; Yang M; Fu H; Hu Z; Liang Y; Yang Z; Zhong R
Mod Rheumatol; 2016; 26(3):372-6. PubMed ID: 26403379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
